Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan:85:10-18.
doi: 10.1016/j.ijsu.2020.11.015. Epub 2020 Nov 21.

Economic evaluation of programs against COVID-19: A systematic review

Aziz Rezapour  1 , Aghdas Souresrafil  2 , Mohammad Mehdi Peighambari  3 , Mona Heidarali  4 , Mahsa Tashakori-Miyanroudi  5
Affiliations

Economic evaluation of programs against COVID-19: A systematic review

Aziz Rezapour et al. Int J Surg. 2021 Jan.

Abstract

Background: The COVID-19 pandemic has become a public health emergency and raised global concerns in about 213 countries without vaccines and with limited medical capacity to treat the disease. The COVID-19 has prompted an urgent search for effective interventions, and there is little information about the money value of treatments. The present study aimed to summarize economic evaluation evidence of preventing strategies, programs, and treatments of COVID-19.

Material and methods: We searched Medline/PubMed, Cochrane Library, Web of Science Core Collection, Embase, Scopus, Google Scholar, and specialized databases of economic evaluation from December 2019 to July 2020 to identify relevant literature to economic evaluation of programs against COVID-19. Two researchers screened titles and abstracts, extracted data from full-text articles, and did their quality assessment by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. Then, quality synthesis of results was done.

Results: Twenty-six studies of economic evaluations met our inclusion criteria. The CHEERS scores for most studies (n = 9) were 85 or higher (excellent quality). Eight studies scored 70 to 85 (good quality), eight studies scored 55 to 70 (average quality), and one study < %55 (poor quality). The decision-analytic modeling was applied to twenty-three studies (88%) to evaluate their services. Most studies utilized the SIR model for outcomes. In studies with long-time horizons, social distancing was more cost-effective than quarantine, non-intervention, and herd immunity. Personal protective equipment was more cost-effective in the short-term than non-intervention. Screening tests were cost-effective in all studies.

Conclusion: The results suggested screening tests and social distancing to be cost-effective alternatives in preventing and controlling COVID-19 on a long-time horizon. However, evidence is still insufficient and too heterogeneous to allow any definite conclusions regarding costs of interventions. Further research as are required in the future.

Keywords: COVID-19; Economic evaluation; Isolation; Lockdown; SARS-COV-2; Screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
PRISMA flow chart for study selection.
Fig. 2
Fig. 2
Reporting Quality of included economic evaluation studies by CHEERS checklist.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li Y., Mutchler J.E. Older adults and the economic impact of the COVID-19 pandemic. J. Aging Soc. Pol. 2020;32(4–5):477–487. - PubMed
    1. Li X.-Z., Jin F., Zhang J.-G., Deng Y.-F., Shu W., Qin J.-M., et al. Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect. Dis. Poverty. 2020;9(1):78. - PMC - PubMed
    1. Jo M.W., Go D.S., Kim R., Lee S.W., Ock M., Kim Y.E., et al. The burden of disease due to COVID-19 in korea using disability-adjusted life years. J. Kor. Med. Sci. 2020;35(21):e199. - PMC - PubMed
    1. Zhao J., Jin H., Li X., Jia J., Zhang C., Zhao H., et al. Disease burden attributable to the first wave of COVID-19 in China, and the effect of timing on the cost-effectiveness of movement restriction policies. https://ssrncom/abstract=3605199. 2020 Available at: SSRN: - PMC - PubMed
    1. Sarah M., Bartsch M.C.F., McKinnell James A., O'Shea Kelly J., Wedlock Patrick T., Siegmund Sheryl S., Lee Bruce Y. The potential health care costs and resource use associated with COVID-19 in the United States. Health Aff. 2020;39(6):927–935. - PMC - PubMed

Publication types